Biomarkers in acute kidney injury: An update;Biomarqueurs dans l'insuffisance rénale aiguë

Revue Medicale Suisse

Volumn 7, Issue 284, 2011, Pages 490-494

  Ariarajah, Niroshini ^a   Gerstel, Eric ^a   Ponte, Belén ^b   Martin, Pierre Yves ^b  

^a SERVICE DE MÉDECINE INTERNE GÉNÉRALE   (Switzerland)

^b HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN L FABP; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIALYSIS; HUMAN; MORTALITY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REVIEW;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; HUMANS;

EID: 79952963697     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Ponte B, Saudan P. L'insuffisance rénale aiguë en 2008. Rev Med Suisse 2008;4:570-5.
2. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: Perspectives on translation. Clin J Am Soc Nephrol 2008;3:481-90.
3. Molitoris BA. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 2003;14:265-7. (Pubitemid 36026318)
4. ** Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and the risk stratification of acute kidney injury: A systematic review. Kidney Int 2008;73:1008-16.
5. Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care 2010;16:533-9.
6. * Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum Cystatin C. Kidney Int 2004;66:1115-22.
7. Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury. Ann Thorac Surg 2009;88:124-30.
8. Soto K, Coelho S, Rodrigues B, et al. Cystatin C as a marker of acute kidney injury in the Emergency department. Clin J Am Soc Nephrol 2010;5:1745-54.
9. Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil- gelatinase-associated lipocalin. J Am Soc Nephrol 2007;18:407-14.
10. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534-43. (Pubitemid 37169339)
11. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005;365:1231-8.
12. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810-9. (Pubitemid 351786928)
13. ** Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012-24.
14. * Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-44.
15. Vaidya VS, Ramirez V, Ichimura T, et al. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. A J Physiol Renal Physiol 2006;290:517-29.
16. * Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004;43:405-14.
17. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16:3046-52. (Pubitemid 44743502)
18. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006;70:199-203.
19. Haase M, Bellomo R, Story D, et al. Urinary IL-18 does not predict acute kidney injury after adult cardiac surgery. Crit Care 2008;12:R96.
20. * Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010;77:708-14.